InvestorsHub Logo
Followers 52
Posts 9087
Boards Moderated 1
Alias Born 10/25/2007

Re: Civil War General post# 12756

Friday, 06/09/2023 7:52:18 AM

Friday, June 09, 2023 7:52:18 AM

Post# of 13457
Moderna is on track to become a multi-product company, and that means it's likely to have many revenue sources down the road.

The company's goal is to capture as much as half of the $30 billion respiratory vaccines market in 2027
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News